Please check your internet connection and try again.
# Lorazepam
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, and anticonvulsant properties.
## Primary Indications
* Anxiety disorders
* Insomnia due to anxiety or transient situational stress
* Preoperative sedation
* Management of seizures (status epilepticus)
* Symptomatic relief of alcohol withdrawal
## Adult Dosing
* **Anxiety:** 1-4 mg every 6-8 hours as needed. Doses up to 10 mg/day may be required in severe cases.
* **Insomnia:** 1-2 mg at bedtime.
* **Preoperative sedation:** 2-4 mg IM or IV 2 hours before surgery.
* **Status epilepticus:** 2-4 mg IV at a rate not exceeding 2 mg/min. May repeat after 10-15 minutes, up to a maximum of 8 mg in a 24-hour period.
## Pediatric Dosing
Dosing in pediatric patients is highly variable and should be based on weight and clinical response. Consult specific pediatric guidelines or protocols.
* **Anxiety:** Generally 0.02-0.05 mg/kg/dose every 4-6 hours. Maximum dose typically 4 mg/day.
* **Status epilepticus:** 0.1 mg/kg IV over 2-5 minutes, not to exceed 4 mg per dose.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution, may require dose reduction.
* **Renal Impairment:** Use with caution, may require dose reduction.
* **Elderly:** Initiate at the lower end of the dosage range, typically 1-2 mg/day divided into doses, due to increased sensitivity and slower metabolism.
## Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Myasthenia gravis.
## Adverse Effects
Common: Drowsiness, dizziness, fatigue, unsteadiness, weakness.
Less common: Confusion, depression, amnesia, paradoxical excitement, visual disturbances, hypotension.
## Key Drug Interactions
* **CNS Depressants (e.g., alcohol, opioids, other sedatives):** Increased risk of profound sedation, respiratory depression, coma, and death.
* **Theophylline and Aminophylline:** May antagonize the sedative effects of lorazepam.
* **Valproic acid:** May increase lorazepam levels.
## Monitoring
* Level of sedation and cognitive function.
* Respiratory rate and oxygen saturation, especially with IV administration or in combination with other CNS depressants.
* Signs of withdrawal upon discontinuation.
* For seizure management, monitor seizure activity and vital signs.
## Clinical Pearls
* Lorazepam has a relatively short half-life compared to some other benzodiazepines, which may reduce the risk of accumulation but can lead to more frequent dosing.
* Avoid abrupt discontinuation; taper dose gradually to prevent withdrawal symptoms.
* IV lorazepam should be administered slowly to avoid paradoxical reactions and respiratory depression. It is not recommended for IM administration in status epilepticus due to erratic absorption.
* When switching from other benzodiazepines, consider equivalent dosing and a slow taper.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the official prescribing information and relevant clinical guidelines for complete and up-to-date information before making any treatment decisions.*
